CNBP welcomes its newest research recruit to Adelaide University, Dr Erin Smith.
Dr Smith will be working with CNBP Chief Investigator Prof. Andrew Abell and his group to explore the synthesis of photoswitchable inhibitors.
Previously, Dr Smith completed a PhD in synthetic chemistry at Curtin University in collaboration with Epichem. She was investigating new biosynthesis inhibitors as a new drug lead for the treatment of Chagas disease.
She has also worked as a postdoctoral researcher at Bayer in Germany. There she was employed as part of the Herbicide Innovation Partnership between Bayer and GRDC (Grains Research and Development Corporation) investigating the synthesis of compounds as potential herbicides for Australian agriculture.